Published in Expert Rev Vaccines on August 01, 2009
Systems vaccinology: learning to compute the behavior of vaccine induced immunity. Wiley Interdiscip Rev Syst Biol Med (2011) 1.19
Vaccinomics, adversomics, and the immune response network theory: individualized vaccinology in the 21st century. Semin Immunol (2013) 1.11
Vaccines, reverse vaccinology, and bacterial pathogenesis. Cold Spring Harb Perspect Med (2013) 1.01
Genome-wide characterization of transcriptional patterns in high and low antibody responders to rubella vaccination. PLoS One (2013) 0.95
Vaccinomics: current findings, challenges and novel approaches for vaccine development. AAPS J (2011) 0.93
Transcriptional profiling of vaccine-induced immune responses in humans and non-human primates. Microb Biotechnol (2011) 0.91
The top five "game changers" in vaccinology: toward rational and directed vaccine development. OMICS (2011) 0.88
Genome-wide mapping of in vivo protein-DNA interactions. Science (2007) 64.92
RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet (2009) 58.77
Global variation in copy number in the human genome. Nature (2006) 57.50
The transcriptional landscape of the yeast genome defined by RNA sequencing. Science (2008) 48.99
Stem cell transcriptome profiling via massive-scale mRNA sequencing. Nat Methods (2008) 31.04
A global view of gene activity and alternative splicing by deep sequencing of the human transcriptome. Science (2008) 29.99
Microbial population structures in the deep marine biosphere. Science (2007) 14.61
mRNA-Seq whole-transcriptome analysis of a single cell. Nat Methods (2009) 11.71
Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells. Nat Biotechnol (2009) 11.18
Evaluation of next generation sequencing platforms for population targeted sequencing studies. Genome Biol (2009) 9.59
Applications of next-generation sequencing technologies in functional genomics. Genomics (2008) 6.50
Next-generation DNA sequencing techniques. N Biotechnol (2009) 6.02
Characterization of mutation spectra with ultra-deep pyrosequencing: application to HIV-1 drug resistance. Genome Res (2007) 5.95
CNV-seq, a new method to detect copy number variation using high-throughput sequencing. BMC Bioinformatics (2009) 5.14
Pyrosequencing analysis of the oral microflora of healthy adults. J Dent Res (2008) 4.71
Simultaneous assessment of soil microbial community structure and function through analysis of the meta-transcriptome. PLoS One (2008) 4.54
Approaches to microRNA discovery. Nat Genet (2006) 4.32
Next-generation sequencing: from basic research to diagnostics. Clin Chem (2009) 4.18
A transcriptional sketch of a primary human breast cancer by 454 deep sequencing. BMC Genomics (2009) 2.27
Heterogeneity in vaccine immune response: the role of immunogenetics and the emerging field of vaccinomics. Clin Pharmacol Ther (2007) 2.17
Genetic basis for adverse events after smallpox vaccination. J Infect Dis (2008) 2.09
Vaccine immunogenetics: bedside to bench to population. Vaccine (2008) 2.01
Massively parallel pyrosequencing highlights minority variants in the HIV-1 env quasispecies deriving from lymphomonocyte sub-populations. Retrovirology (2009) 1.99
Personalized vaccines: the emerging field of vaccinomics. Expert Opin Biol Ther (2008) 1.59
Massive parallel MHC genotyping: titanium that shines. Mol Ecol (2009) 1.13
Large-scale genomic analysis of ovarian carcinomas. Mol Oncol (2008) 1.12
Studies of twins in vaccinology. Vaccine (2007) 1.02
Microbe-induced epigenetic alterations in host cells: the coming era of patho-epigenetics of microbial infections. A review. Acta Microbiol Immunol Hung (2009) 0.95
Next-generation sequencing of plasma/serum DNA: an emerging research and molecular diagnostic tool. Clin Chem (2009) 0.84
Genome sequences from extinct relatives. Cell (2008) 0.79
Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet (2001) 22.07
Cloning and characterization of the common fragile site FRA6F harboring a replicative senescence gene and frequently deleted in human tumors. Oncogene (2002) 5.40
Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation. Proc Natl Acad Sci U S A (2005) 3.16
Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss. Nat Genet (2011) 3.16
Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon. Clin Cancer Res (2005) 2.98
A role for common fragile site induction in amplification of human oncogenes. Cancer Cell (2002) 2.63
Alterations in the common fragile site gene Parkin in ovarian and other cancers. Oncogene (2003) 2.44
Loss of HSulf-1 up-regulates heparin-binding growth factor signaling in cancer. J Biol Chem (2003) 2.40
Gene expression profiles predict early relapse in ovarian cancer after platinum-paclitaxel chemotherapy. Clin Cancer Res (2005) 2.29
Malignant pheochromocytoma: current status and initiatives for future progress. Endocr Relat Cancer (2004) 2.20
Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas. Oncogene (2002) 2.16
Myopericarditis following smallpox vaccination among vaccinia-naive US military personnel. JAMA (2003) 2.15
3' tag digital gene expression profiling of human brain and universal reference RNA using Illumina Genome Analyzer. BMC Genomics (2009) 2.12
Developing the next generation of vaccinologists. Vaccine (2010) 2.07
Long, abundantly expressed non-coding transcripts are altered in cancer. Hum Mol Genet (2007) 2.00
Common fragile sites are preferential targets for HPV16 integrations in cervical tumors. Oncogene (2003) 2.00
Mutations in CHEK2 associated with prostate cancer risk. Am J Hum Genet (2003) 1.96
Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas. Blood (2012) 1.96
hSulf1 Sulfatase promotes apoptosis of hepatocellular cancer cells by decreasing heparin-binding growth factor signaling. Gastroenterology (2004) 1.95
Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing. Blood (2010) 1.90
Tumor transcriptome sequencing reveals allelic expression imbalances associated with copy number alterations. PLoS One (2010) 1.85
HSulf-1 modulates HGF-mediated tumor cell invasion and signaling in head and neck squamous carcinoma. Oncogene (2004) 1.82
Immunosenescence: role and measurement in influenza vaccine response among the elderly. Vaccine (2007) 1.78
2009 H1N1 influenza. Mayo Clin Proc (2009) 1.76
The contribution of HLA class I antigens in immune status following two doses of rubella vaccination. Hum Immunol (2004) 1.70
Dysregulated microRNAs and their predicted targets associated with endometrioid endometrial adenocarcinoma in Hong Kong women. Int J Cancer (2009) 1.68
Detection of smallpox virus DNA by LightCycler PCR. J Clin Microbiol (2002) 1.62
Associations between SNPs in toll-like receptors and related intracellular signaling molecules and immune responses to measles vaccine: preliminary results. Vaccine (2008) 1.60
AGR2, an androgen-inducible secretory protein overexpressed in prostate cancer. Genes Chromosomes Cancer (2005) 1.58
Vaccines against avian influenza--a race against time. N Engl J Med (2006) 1.57
Acquisition of high-level chromosomal instability is associated with integration of human papillomavirus type 16 in cervical keratinocytes. Cancer Res (2004) 1.56
Human leukocyte antigen haplotypes in the genetic control of immune response to measles-mumps-rubella vaccine. J Infect Dis (2006) 1.54
MANF: a new mesencephalic, astrocyte-derived neurotrophic factor with selectivity for dopaminergic neurons. J Mol Neurosci (2003) 1.54
Influenza vaccination among registered nurses: information receipt, knowledge, and decision-making at an institution with a multifaceted educational program. Infect Control Hosp Epidemiol (2008) 1.50
A candidate tumor suppressor HtrA1 is downregulated in ovarian cancer. Oncogene (2004) 1.47
Rubella vaccine-induced cellular immunity: evidence of associations with polymorphisms in the Toll-like, vitamin A and D receptors, and innate immune response genes. Hum Genet (2009) 1.46
Assessing participation bias in a population-based study of measles-mumps-rubella vaccine immunity in children and adolescents aged 12-18. Paediatr Perinat Epidemiol (2007) 1.45
Independence of measles-specific humoral and cellular immune responses to vaccination. Hum Immunol (2012) 1.44
If you could halve the mortality rate, would you do it? Clin Infect Dis (2002) 1.42
FusionHunter: identifying fusion transcripts in cancer using paired-end RNA-seq. Bioinformatics (2011) 1.41
Human leukocyte antigen and cytokine receptor gene polymorphisms associated with heterogeneous immune responses to mumps viral vaccine. Pediatrics (2008) 1.41
The association of CD46, SLAM and CD209 cellular receptor gene SNPs with variations in measles vaccine-induced immune responses: a replication study and examination of novel polymorphisms. Hum Hered (2011) 1.40
Confronting bioterrorism: physicians on the front line. Mayo Clin Proc (2002) 1.40
Asthma and the immune response to MMR vaccine viruses in Somali immigrant children: a cross-sectional retrospective cohort study. Prim Care Respir J (2013) 1.40
Revised SHEA position paper: influenza vaccination of healthcare personnel. Infect Control Hosp Epidemiol (2010) 1.39
Zoster vaccine recommendations: the importance of using a clinically valid correlate of protection. Vaccine (2011) 1.39
Gender effects on humoral immune responses to smallpox vaccine. Vaccine (2009) 1.39
Methodologic reporting requirements for clinical trials: advancing the science today and tomorrow. Vaccine (2011) 1.37
Associations between measles vaccine immunity and single-nucleotide polymorphisms in cytokine and cytokine receptor genes. J Infect Dis (2006) 1.35
Immunization and the prevention of influenza and pneumococcal disease in people with diabetes. Diabetes Care (2003) 1.35
Human leukocyte antigen class II alleles and rubella-specific humoral and cell-mediated immunity following measles-mumps-rubella-II vaccination. J Infect Dis (2005) 1.35
High detection rates of colorectal neoplasia by stool DNA testing with a novel digital melt curve assay. Gastroenterology (2008) 1.34
Genome-wide gene expression profiling of cervical cancer in Hong Kong women by oligonucleotide microarray. Int J Cancer (2006) 1.32
Polymorphisms in the vitamin A receptor and innate immunity genes influence the antibody response to rubella vaccination. J Infect Dis (2010) 1.31
Human TopBP1 ensures genome integrity during normal S phase. Mol Cell Biol (2005) 1.31
2'-5'-Oligoadenylate synthetase single-nucleotide polymorphisms and haplotypes are associated with variations in immune responses to rubella vaccine. Hum Immunol (2010) 1.30
Identification of underexpressed genes in early- and late-stage primary ovarian tumors by suppression subtraction hybridization. Cancer Res (2002) 1.29
HLA class II alleles and measles virus-specific cytokine immune response following two doses of measles vaccine. Immunogenetics (2005) 1.28
Associations between single nucleotide polymorphisms and haplotypes in cytokine and cytokine receptor genes and immunity to measles vaccination. Vaccine (2011) 1.24
Epigenetic silencing of TCEAL7 (Bex4) in ovarian cancer. Oncogene (2005) 1.24
Variations in measles vaccine-specific humoral immunity by polymorphisms in SLAM and CD46 measles virus receptors. J Allergy Clin Immunol (2007) 1.24
Biallelic methylation and silencing of paternally expressed gene 3 (PEG3) in gynecologic cancer cell lines. Gynecol Oncol (2005) 1.24
Genome-wide association study of antibody response to smallpox vaccine. Vaccine (2012) 1.23
Immunization programs for infants, children, adolescents, and adults: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis (2009) 1.22
The common fragile site FRA16D and its associated gene WWOX are highly conserved in the mouse at Fra8E1. Genes Chromosomes Cancer (2002) 1.22
Development of a novel efficient fluorescence-based plaque reduction microneutralization assay for measles virus immunity. Clin Vaccine Immunol (2008) 1.21
LSINCT5 is over expressed in breast and ovarian cancer and affects cellular proliferation. RNA Biol (2011) 1.21
Characterization of FRA6E and its potential role in autosomal recessive juvenile parkinsonism and ovarian cancer. Genes Chromosomes Cancer (2003) 1.21
Calculating sample size estimates for RNA sequencing data. J Comput Biol (2013) 1.21
Hepatitis B vaccine nonresponse and celiac disease. Am J Gastroenterol (2003) 1.20
A large observational study to concurrently assess persistence of measles specific B-cell and T-cell immunity in individuals following two doses of MMR vaccine. Vaccine (2011) 1.18
Human leukocyte antigen genotypes in the genetic control of adaptive immune responses to smallpox vaccine. J Infect Dis (2011) 1.18
Systems biology approaches to new vaccine development. Curr Opin Immunol (2011) 1.17
Identification of long stress-induced non-coding transcripts that have altered expression in cancer. Genomics (2010) 1.17
The role of polymorphisms in Toll-like receptors and their associated intracellular signaling genes in measles vaccine immunity. Hum Genet (2011) 1.17
Replication of rubella vaccine population genetic studies: validation of HLA genotype and humoral response associations. Vaccine (2009) 1.17
Genome-wide analysis of polymorphisms associated with cytokine responses in smallpox vaccine recipients. Hum Genet (2012) 1.15
SNP/haplotype associations in cytokine and cytokine receptor genes and immunity to rubella vaccine. Immunogenetics (2010) 1.15
Immunologic significance of HLA class I genes in measles virus-specific IFN-gamma and IL-4 cytokine immune responses. Immunogenetics (2005) 1.13
Preferential integration of human papillomavirus type 18 near the c-myc locus in cervical carcinoma. Oncogene (2003) 1.13
Genetic polymorphisms in host antiviral genes: associations with humoral and cellular immunity to measles vaccine. Vaccine (2011) 1.12
Role of decreased levels of lipid phosphate phosphatase-1 in accumulation of lysophosphatidic acid in ovarian cancer. Clin Cancer Res (2003) 1.12
Transcriptional repression of WEE1 by Kruppel-like factor 2 is involved in DNA damage-induced apoptosis. Oncogene (2005) 1.12
Influenza and pneumococcal immunization in diabetes. Diabetes Care (2004) 1.11
Influence of host genetic variation on rubella-specific T cell cytokine responses following rubella vaccination. Vaccine (2009) 1.10
Mechanisms of genomic instabilities underlying two common fragile-site-associated loci, PARK2 and DMD, in germ cell and cancer cell lines. Am J Hum Genet (2010) 1.10
HLA supertypes and immune responses to measles-mumps-rubella viral vaccine: findings and implications for vaccine design. Vaccine (2007) 1.10
Mutability in the matrix gene of novel influenza A H1N1 virus detected using a FRET probe-based real-time reverse transcriptase PCR assay. J Clin Microbiol (2009) 1.10
The immunology of smallpox vaccines. Curr Opin Immunol (2009) 1.10
Vaccinating health care workers against influenza: the ethical and legal rationale for a mandate. Am J Public Health (2011) 1.10
Frequency of measles virus-specific CD4+ and CD8+ T cells in subjects seronegative or highly seropositive for measles vaccine. Clin Diagn Lab Immunol (2003) 1.10
Influenza vaccines: from surveillance through production to protection. Mayo Clin Proc (2010) 1.09